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Objective. To compare wound infection, revision rates and hospital stay after major lower limb amputation between
patients receiving 24 hours versus 5 days of prophylactic antibiotics.
Methods. The outcomes of a consecutive series of 40 major lower limb amputations in patients receiving a short 24-hour
course of combined prophylactic antibiotics (flucloxacillin/vancomycin þ gentamicin/ciproxin þ metronidazole) were
retrospectively analysed. Following this a further consecutive group of 40 major lower limb amputations were studied
prospectively following the institution of a 5-day combined regime using the same antibiotics.
Results. The 2 groups of patients were similar in terms of demographics, vascular risk factors and level of amputation. The
5-day antibiotic regime led to a significant reduction in wound infection rates (5% vs. 22.5%, P¼ 0.023) and a reduced
length of hospital stay (22 vs. 34 days, P¼ 0.001). Revision rates were lower (2.5% vs. 10%) but did not reach statistical
significance (P¼ 0.36). More patients in the prospective 5-day antibiotic series were operated on by the vascular trainee.
(77.5% vs. 55% P¼ 0.033).
Conclusions. This data supports the use of a prolonged 5-day course of combined antibiotics after major lower limb
amputation. This appears to reduce stump infection rates leading to shorter in-hospital stay.
 2007 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Wound infection rates ranging from 13e40% have
been reported following major lower limb amputa-
tion.1e4 Several factors known to contribute to wound
sepsis come into play with amputations- ischaemia,
pre-existing limb ulceration and gangrene,5 patient
co-morbidities 6 and wound contamination.4 Careful
selection of the amputation level, optimal surgical
techniques and appropriate antibiotic prophylaxis are
required to minimise infection rates.
There is evidence that 30e45% of legs are already
colonised with pathogenic bacteria prior to amputa-
tion.3,4 This clearly is an important factor in the high
rates of wound infection reported and highlights the
importance of prophylactic antibiotics. The aim of
this study was to evaluate whether a change in anti-
biotic prophylaxis policy could reduce stump sepsis
rates. In particular the role of a prolonged 5-day course
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ied. Although in general long courses of antibiotics for
prophylaxis are not recommended,7e9 isolated reports
of benefit from such an approach do exist.10
Materials and Methods
A retrospective audit of the outcome of all major lower
limb amputations performed in a 15-month period
between January 1st 2003 and April 1st 2004 in the
Cambridge Vascular Unit was carried out. Details of all
patients undergoing either a below (BKA) or above
knee amputation (AKA)were obtained from the clinical
and theatre databases. Data was extracted from the pa-
tient records,with swab results from the hospital pathol-
ogy database. Patient demographics, co-morbidities,
reason for amputation, operative details, antibiotic pro-
phylaxis, and stump outcome were recorded. We relied
on the clinical recording of stump infection based on cel-
lulitis, positive swab cultures and purulent discharge
with wound breakdown. The unit antibiotic protocol
during thisperiodwasa combinationof broad-spectrum
agents with 1 dose given at the time of surgery and twolar Surgery. Published by Elsevier Ltd. All rights reserved.
76 U. Sadat et al.postoperative doses 8-hourly. The regime was as
follows: - flucloxacillin 1 g or vancomycin 1 g for gram-
positive cover. Vancomycin was used for penicillin aller-
gic patients and where MRSAwas present or suspected
clinically. Gentamicin 120 mgs or ciprofloxacin 200 mgs
were prescribed for gram-negative cover. Ciprofloxacin
was used instead of gentamicin when there were con-
cerns about renal function. Metronidazole 500 mgs was
used for anaerobic cover. All were given intravenously.
Following this audit, a change to the antibiotic pro-
tocol was introduced with an intentional 5-day course
of the same antibiotic regime given at standard inter-
vals. Oral therapy was used as soon as appropriate be-
yond the first 24 hours. The outcome of a second
consecutive series of below and above knee amputa-
tions was prospectively evaluated between January
1st 2005 and April 1st 2006. Wounds were inspected
daily from day 5 post amputation until discharge.
Infection was defined as the presence of a purulent
discharge, or cellulitis with positive wound cultures.
The data collection was done according to a preset pro-
tocol similar to the one used for retrospective cohort.
Statistical analysis
Continuous variables were summarised as medians
with interquartile ranges and comparisons were made
using the Mann-Whitney rank sum test. Associations
between categorical variables were tested with the
Chi-square test, or Fisher’s exact if the expected
frequency of at least 1 cell was found to be less than 5.
Results
38 patients underwent 40 major limb amputations in
each 15 month audited period (2 bilateral amputees
in each series, 39 being vascular amputations and
one for chronic pain and atrophic muscles). The pa-
tient demographics and major vascular risk factors
are shown in Table 1. The age and gender distribution
was similar in both groups as was the incidence of
diabetes and hypertension. There were significantly
more current smokers (79% vs. 39.5%) in the 5-day
antibiotic cohort. There was no significant difference
in ASA status. Exactly half the amputations in the 3
dose antibiotic group were above the knee (AKA:
BKA ratio 20: 20). There was an almost identical ratio
of AKA: BKA in the 5-day antibiotic group (19: 21).
Seven patients (17%) in the 3-dose antibiotic group
were given antibiotics that differed from the recommen-
ded regime. These were all patients operated on as
emergencies out of hourswho received a cephalosporin
for gram positive and negative cover rather thanEur J Vasc Endovasc Surg Vol 35, January 2008flucloxacillin and gentamicin. In the prospective 5-day
antibiotic cohort, all patients were treated within the
recommended regime.
Fig. 1 shows the wound infection rates in the two
cohorts. Patients receiving 5 days of antibiotic cover
had significantly lower wound infection rates (5% vs.
22.5%, P¼ 0.02). This was associated with a lower rate
of stump revision procedures (2.5% vs. 10%) but due
to the small numbers this did not reach statistical signif-
icance (P¼ 0.36). Three patients had cellulitis and 6 had
a wound discharge with positive cultures in the 3 dose
antibiotic cohort. In the 5 day antibiotic cohort 2 patients
had both cellulitis and a wound discharge with positive
wound cultures. Patients undergoing below knee
amputations had a higher incidence of infection in the
Table 1. Demographics of the two groups of patients
Patient
characteristics
3 dose
antibiotics
(n¼ 38) n (%)
5 day
antibiotics
(n¼ 38) n (%)
p.value
Mann-Whitney
Age, median (IQR) 74 (63e83) 75 (63e79) 0.655
Sex
Male 26 (68.4) 28 (73.7)
Female 12 (31.6) 10 (26.3) 0.613
Diabetic
Yes 15 (39.5) 20 (52.6)
No 23 (60.5) 18 (47.4) 0.250
Smoker
Yes 15 (39.5) 30 (79.0)
No 23 (60.5) 8 (21.0) <0.001
Hypertension
Yes 22 (57.9) 23 (60.5)
No 16 (42.1) 15 (39.5) 0.815
ASA grade
1 2 (5.0) 0 (0.0)
2 4 (11.0) 1 (2.0)
3 17 (45.0) 31 (82) Chi-square
for trend
4 15 (39.0) 6 (16.0) 0.603
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Fig. 1. Histogram showing percentage difference between
two groups of patients with regards to infection, MRSA
and revision of the amputation.
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reach statistical significance. The incidence of MRSA
infection was 4 (10%) in the 3 dose antibiotic group
and 0 (0%) in the 5-day group.
The seniority of the operating surgeon did not ap-
pear to influence the stump infection or revision rates.
Patients in the 5-day antibiotic group were in fact
more likely to be operated on by the Surgical Trainee
(year 5/6 surgical residents) than in the 3-dose group
(77.5% vs. 55%). The total in-hospital length of stay is
shown in Fig. 2. There was a significant reduction in
length of stay in the 5-day antibiotic group (22 vs. 34
days, P¼ 0.001). There were 5 in-hospital deaths
(12.5%) for the 3-dose antibiotic group and 1 (2.5%)
for the 5-day antibiotic group. All deaths were due to
myocardial infarction.Mortalitywas linked toASA sta-
tus, 3 of 5 deaths in the 3 dose antibiotic cohort were
ASA4, the singlemortality in the 5 day antibiotic cohort
was ASA 4. This difference did not reach statistical
significance (P¼ 0.2, Fisher’s exact test).
Although therewere 7patients in the retrospective 3-
dose groupwho received cephalosporins outside of the
recommended regime, only 1 of these patients (14%)
developed awound infection. Therewas concern about
the risk of acquiring clostridium difficile infection with
the 5-day course of antibiotics. Threepatients (7.5%)de-
veloped diarrhoea positive for C. difficile toxin in this
group. The incidence of C.Difficile infection in the ret-
rospective 3-dose group was not recorded.
Discussion
Thefirst cohort of 40 amputees in this studyhada ‘‘stan-
dard’’ antibiotic prophylactic regime with a dose given
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Fig. 2. Scatter plot showing the spread of the hospital stay
between the two patient groups.at the time of surgery and 2 postoperative doses eight
hours apart. This protocol however was associated
with a high stump infection rate of 22.5%. Anecdotal re-
ports of longer courses of antibiotics reducing infection
rates led us to consider introducing a 5 dayprophylactic
regime.10 Hall and colleagues prospectively rando-
mised 302 patients undergoing vascular reconstructive
procedures to a single dose antibiotic regime or amulti-
dose regime. The latter was maintained until all lines
were removed, a mean of 3 days with a maximum set
at 5 days. The multidose group had a lower wound in-
fection rate of 10% vs. 18% P¼ 0.04. Earnshaw et al. in
a previous, though smaller, study had failed to find
any benefit of a longer 5-day course of antibiotics.5 Nei-
ther of these studies included amputees. Very few stud-
ies have looked specifically at the role of antibiotics in
major lower limb amputation. Huizinga and colleagues
reported a large reduction in stump infection rates from
77% to 13% with the use of broad spectrum agents
rather than penicillin alone.1 The wide range of organ-
isms cultured pre and post amputation in the study of
amputees by Berridge et al.4 confirm the need for
a broad spectrum of cover by antibiotics. No strong
data exists however on the optimum duration of anti-
biotic administration for amputees.
Despite the fact that longer courses of prophylactic
antibiotics are usually not recommended, there is evi-
dence that they are oftenused especially in cardiovascu-
lar surgery.11 We therefore adopted a longer course of
prophylaxis and audited the effect on stump infection
rates prospectively in a similar group of amputees. No
other aspect of routine management was altered. The
result was a significant reduction in stump infection
rates associated with a reduced overall hospital stay.
The impact on hospital stay was a surprising finding
since stump healing alone often does not keep patients
in hospital. Home adjustments and rehabilitation issues
often have amore direct bearing ondischarge planning.
These may have been delayed in patients with infected
stumps leading to slower discharge.
There were amputees in the first cohort who re-
ceived antibiotics outside of the recommended regime.
This highlights the uncontrolled nature of such a retro-
spective study. However, this subgroup of patients did
not result in a large number of infections and therefore
did not influence significantly the high overall infection
rate. The prospective cohort of patients proved to be
well matched in terms of age, gender and major vascu-
lar co-morbidities other than higher incident of smok-
ing in this group, which may be an incidental finding.
These other factors cannot therefore explain the major
reduction in wound infection rate found in this study.
Advocating a 5-day regime of antibiotics for lower
limb amputations is controversial. The findings of this
78 U. Sadat et al.study clearly require confirmation in further studies.
Ideally a randomised trial would provide more defini-
tive data. Organisation of amulti centred trial was con-
sidered after the first audit of stump infection rates. The
logistics of this proved to be a major hurdle and a re-
audit using a 5 day antibiotic regime within the same
single centre was therefore undertaken. The delay be-
tween the two audits was largely due to the time spent
working on a possiblemulti centred trial. Other aspects
of amputation stump sepsis that require further study,
are the rates of pre-existing stump colonisation with
bacteria, an extension of the previouswork by Berridge
and colleagues.4 Can other techniques such as stump
lavage, help in contaminated stumps? Could longer
courses of antibiotics be targeted only at amputees
with positive intra-operative stump cultures?
Concerns about the development of antimicrobial
resistance and Clostridium difficile infections favour
shorter regimes of prophylaxis. Clearly there is an im-
portant balance to strike with major lower limb ampu-
tations between the need to minimise stump infection
rates, which are often high, and the detrimental effects
of excessive antibiotic usage. However, the significant
reduction in wound infection rates in this study can-
not be ignored. There may well be a place for targeted
more intense antibiotic regimes in major limb amputa-
tion, guided by wound culture. Further research into
the effect of such an approach is required.
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